Periactin is a medicine containing the active ingredient(s) cyproheptadine. On this page you will find out more about Periactin, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cyproheptadine
Over 65 years of age?
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Information for medicine and pack size:
Periactin 4 mg uncoated tablet, 50
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
Use as an antiallergic-antipruritic agent and relief of migraine and vascular types of headaches.
Table of characteristics
White, flat circular, bevel edged tablet containing 4 mg of cyproheptadine hydrochloride. Marked 'P4' on one side, scored on the other
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Tablet, uncoated|
|Route of administration||Oral|
50 & 100: Pharmacist Only Medicine (Over the counter)
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 3 results
Periactin Tablets - myDr.com.au
Periactin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Angioedema - Australasian Society of Clinical Immunology and Allergy (ASCIA)
Angioedema is a condition in which small blood vessels leak fluid into the tissues, causing swelling. There is no known cure, but it may be possible to prevent the swelling with medications or occasionally diet. Allergy is a very rare cause of angioedema.
Read more on ASCIA – Australasian Society of Clinical Immunology and Allergy website
Hay fever treatments - myDr.com.au
Antihistamines work fast and are good at treating mild symptoms of hay fever, such as sneezing and runny nose, whereas corticosteroid nasal sprays may take several days to work.
Read more on myDr website
Found 1 results
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia | Cochrane
Tardive dyskinesia is a disfiguring and disabling disorder of voluntary control of movement, often caused by antipsychotic drugs. Several Cochrane reviews have summarised the effects of the many treatments used to manage these involuntary movements. This review summarises the trial-based evidence of a miscellaneous group of compounds (botulin toxin, endorphin, essential fatty acid, EX11582A, ganglioside, insulin, lithium, naloxone, oestrogen, periactin, phenylalanine, piracetam, stepholidine, tryptophan, neurosurgery, or ECT) none of which were found to be effective for tardive dyskinesia.
Read more on Cochrane (Australasian Centre) website